atbtherapeutics
New

Director Preclinical Development

Ghent, East-Flanders, GhentPermanent - Full Timeexecutive
OtherDevelopment
0 views0 saves0 applied

Quick Summary

Overview

ATB Therapeutics is a Biotech company developing a cutting-edge technology to produce a new kind of targeted therapy designed to treat cancers and auto-immune diseases. ATB Therapeutics has two Belgian R&D sites located in the Novalis Science Park (Marche-en-Famenne) and the VIB incubator (Ghent).

Technical Tools
OtherDevelopment
ATB Therapeutics is a Biotech company developing a cutting-edge technology to produce a new kind of targeted therapy designed to treat cancers and auto-immune diseases. ATB Therapeutics has two Belgian R&D sites located in the Novalis Science Park (Marche-en-Famenne) and the VIB incubator (Ghent).  

The company closed a successful Series A financing round of Euro 54 million in November 2024, and is backed by leading European and US investors.

To support our growing team, we are looking for a Director Preclinical Development to join us in Ghent, helping us to align between product profile, preclinical data and clinical development objectives. 





Location & Eligibility

Where is the job
Location terms not specified
Who can apply
Same as job location

Listing Details

First seen
May 6, 2026
Last seen
May 7, 2026

Posting Health

Days active
0
Repost count
0
Trust Level
52%
Scored at
May 6, 2026

Signal breakdown

freshnesssource trustcontent trustemployer trust

1 other job at atbtherapeutics

View all →

Explore open roles at atbtherapeutics.

Newsletter

Stay ahead of the market

Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.

A
B
C
D
Join 12,000+ marketers

No spam. Unsubscribe at any time.

atbtherapeuticsDirector Preclinical Development